Approval · Notice of Compliance 17054 · 2015
ZEMURON: Notice of Compliance 17054
Issued July 6, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17054
- Date
- July 6, 2015
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the primary container closure system
- Therapeutic class
- Non-depolarizing skeletal neuromuscular blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEMURON | Not yet assigned | — |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML